Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Harrison

Showing results (1-10 of 261) with videos related to

Pageof 27
Sort By:
Oncogene|March 1, 2005
p53 deficiency exacerbates pleiotropic mitotic defects, changes in nuclearity and polyploidy in transdifferentiating pancreatic acinar cellsNathalie Sphyris, David J Harrison
Current Drug Targets|September 15, 2012
Molecular pathology in therapeutics: where are we now, and where are we going?David J Harrison, Dana Faratian
Toxicology Research|September 6, 2021
The modification of cancer risk by chemicalsDavid J Harrison, John E Doe
The New England Journal of Medicine|February 22, 2002
Lack of health insurance and overall healthDavid J Harrison, Andrea K Biddle
Case Reports in Orthopedics|December 3, 2013
The use of percutaneous lumbar fixation screws for bilateral pedicle fractures with an associated dislocation of a lumbar disc prosthesisWilliam D Harrison, David J Harrison
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2015
Next-Generation PathologyPeter D Caie, David J Harrison
Experimental and Molecular Pathology|June 9, 2005
Integrin characterization in pulmonary bronchiolesRenald A Blundell, David J Harrison
Pharmacology & Therapeutics|August 19, 2008
Beta1 integrin in tissue remodelling and repair: from phenomena to conceptsRehab Al-Jamal, David J Harrison
Diagnostics (Basel, Switzerland)|March 13, 2024
Magnifying Networks for Histopathological Images with Billions of PixelsNeofytos Dimitriou, Ognjen Arandjelović, David J Harrison
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 24, 2010
Dosing patterns and costs of tumor necrosis factor inhibitor use for rheumatoid arthritisDavid J Harrison, Xingyue Huang, Denise Globe
Pageof 27

Showing results (1-10 of 261) with videos related to

Sort By:
Pageof 27
Oncogene|March 1, 2005
p53 deficiency exacerbates pleiotropic mitotic defects, changes in nuclearity and polyploidy in transdifferentiating pancreatic acinar cellsNathalie Sphyris, David J Harrison
Current Drug Targets|September 15, 2012
Molecular pathology in therapeutics: where are we now, and where are we going?David J Harrison, Dana Faratian
Toxicology Research|September 6, 2021
The modification of cancer risk by chemicalsDavid J Harrison, John E Doe
The New England Journal of Medicine|February 22, 2002
Lack of health insurance and overall healthDavid J Harrison, Andrea K Biddle
Case Reports in Orthopedics|December 3, 2013
The use of percutaneous lumbar fixation screws for bilateral pedicle fractures with an associated dislocation of a lumbar disc prosthesisWilliam D Harrison, David J Harrison
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2015
Next-Generation PathologyPeter D Caie, David J Harrison
Experimental and Molecular Pathology|June 9, 2005
Integrin characterization in pulmonary bronchiolesRenald A Blundell, David J Harrison
Pharmacology & Therapeutics|August 19, 2008
Beta1 integrin in tissue remodelling and repair: from phenomena to conceptsRehab Al-Jamal, David J Harrison
Diagnostics (Basel, Switzerland)|March 13, 2024
Magnifying Networks for Histopathological Images with Billions of PixelsNeofytos Dimitriou, Ognjen Arandjelović, David J Harrison
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 24, 2010
Dosing patterns and costs of tumor necrosis factor inhibitor use for rheumatoid arthritisDavid J Harrison, Xingyue Huang, Denise Globe
Pageof 27